Therapeutic strategies aiming to amplify AID expression within tumor microenvironments (TME) could theoretically enhance TLS maturation, with proposed methodologies including localized delivery of AID-overexpressing vectors followed by immunohistochemical validation of TLS structural completeness. Here, AICDA is linked to neoplasm.